Faes Farma, S.A. (FAE.MC)
EUR 3.33
(-2.49%)
EUR 3.33
(-2.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 91.9 Million EUR | 2.69% |
| 2022 | 89.49 Million EUR | 8.62% |
| 2021 | 82.39 Million EUR | 13.56% |
| 2020 | 72.54 Million EUR | 13.43% |
| 2019 | 63.96 Million EUR | 23.98% |
| 2018 | 51.59 Million EUR | 22.2% |
| 2017 | 42.22 Million EUR | 15.39% |
| 2016 | 36.59 Million EUR | 20.52% |
| 2015 | 30.36 Million EUR | 19.84% |
| 2014 | 25.33 Million EUR | 12.07% |
| 2013 | 22.6 Million EUR | 15.82% |
| 2012 | 19.51 Million EUR | 37.63% |
| 2011 | 14.18 Million EUR | -29.1% |
| 2010 | 20 Million EUR | 10.14% |
| 2009 | 18.16 Million EUR | -7.41% |
| 2008 | 19.61 Million EUR | -11.44% |
| 2007 | 22.14 Million EUR | -2.74% |
| 2006 | 22.77 Million EUR | -2.15% |
| 2005 | 23.27 Million EUR | -2.19% |
| 2004 | 23.79 Million EUR | 21.8% |
| 2003 | 19.53 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 27.89 Million EUR | -8.45% |
| 2024 Q1 | 30.46 Million EUR | -21.69% |
| 2023 FY | 91.9 Million EUR | 2.69% |
| 2023 Q3 | 21.16 Million EUR | -16.64% |
| 2023 Q4 | 38.9 Million EUR | 83.85% |
| 2023 Q1 | 27.61 Million EUR | 77.51% |
| 2023 Q2 | 25.38 Million EUR | -8.08% |
| 2022 Q2 | 26.28 Million EUR | -1.24% |
| 2022 Q3 | 21.08 Million EUR | -19.79% |
| 2022 Q4 | 15.55 Million EUR | -26.22% |
| 2022 Q1 | 26.61 Million EUR | 121.83% |
| 2022 FY | 89.49 Million EUR | 8.62% |
| 2021 Q2 | 25.7 Million EUR | 19.65% |
| 2021 FY | 82.39 Million EUR | 13.56% |
| 2021 Q4 | 12 Million EUR | -49.92% |
| 2021 Q3 | 23.96 Million EUR | -6.78% |
| 2021 Q1 | 21.48 Million EUR | 129.82% |
| 2020 FY | 72.54 Million EUR | 13.43% |
| 2020 Q1 | 20.84 Million EUR | 87.62% |
| 2020 Q2 | 24.73 Million EUR | 18.65% |
| 2020 Q3 | 17.61 Million EUR | -28.77% |
| 2020 Q4 | 9.34 Million EUR | -46.93% |
| 2019 Q3 | 16.24 Million EUR | -19.67% |
| 2019 Q2 | 20.22 Million EUR | 23.52% |
| 2019 FY | 63.96 Million EUR | 23.98% |
| 2019 Q1 | 16.37 Million EUR | 67.23% |
| 2019 Q4 | 11.11 Million EUR | -31.62% |
| 2018 Q2 | 15.44 Million EUR | 12.23% |
| 2018 Q4 | 9.79 Million EUR | -22.65% |
| 2018 FY | 51.59 Million EUR | 22.2% |
| 2018 Q1 | 13.75 Million EUR | 44.49% |
| 2018 Q3 | 12.66 Million EUR | -18.01% |
| 2017 Q3 | 11.5 Million EUR | -3.3% |
| 2017 FY | 42.22 Million EUR | 15.39% |
| 2017 Q1 | 9.3 Million EUR | 43.28% |
| 2017 Q4 | 9.52 Million EUR | -17.24% |
| 2017 Q2 | 11.89 Million EUR | 27.91% |
| 2016 FY | 36.59 Million EUR | 20.52% |
| 2016 Q4 | 6.49 Million EUR | -43.01% |
| 2016 Q3 | 11.39 Million EUR | 7.35% |
| 2016 Q2 | 10.61 Million EUR | 30.99% |
| 2016 Q1 | 8.1 Million EUR | 59.29% |
| 2015 Q2 | 8.76 Million EUR | 28.96% |
| 2015 Q3 | 9.7 Million EUR | 10.7% |
| 2015 Q4 | 5.08 Million EUR | -47.62% |
| 2015 FY | 30.36 Million EUR | 19.84% |
| 2015 Q1 | 6.8 Million EUR | 115.33% |
| 2014 Q3 | 8.12 Million EUR | -2.59% |
| 2014 Q4 | 3.15 Million EUR | -61.14% |
| 2014 Q2 | 8.34 Million EUR | 46.37% |
| 2014 FY | 25.33 Million EUR | 12.07% |
| 2014 Q1 | 5.7 Million EUR | 334.12% |
| 2013 Q2 | 4.85 Million EUR | -38.08% |
| 2013 Q3 | 8.58 Million EUR | 76.8% |
| 2013 Q4 | 1.31 Million EUR | -84.71% |
| 2013 FY | 22.6 Million EUR | 15.82% |
| 2013 Q1 | 7.84 Million EUR | 3764.53% |
| 2012 Q1 | 6.24 Million EUR | 1874.72% |
| 2012 Q3 | 9.99 Million EUR | 225.81% |
| 2012 FY | 19.51 Million EUR | 37.63% |
| 2012 Q4 | 203 Thousand EUR | -97.97% |
| 2012 Q2 | 3.06 Million EUR | -50.87% |
| 2011 Q1 | 8.18 Million EUR | 0.0% |
| 2011 Q4 | -352 Thousand EUR | -108.55% |
| 2011 Q3 | 4.11 Million EUR | 85.0% |
| 2011 FY | 14.18 Million EUR | -29.1% |
| 2011 Q2 | 2.22 Million EUR | -72.82% |
| 2010 Q1 | 8.4 Million EUR | 0.0% |
| 2010 FY | 20 Million EUR | 10.14% |
| 2010 Q2 | 4.28 Million EUR | -49.05% |
| 2009 FY | 18.16 Million EUR | -7.41% |
| 2008 FY | 19.61 Million EUR | -11.44% |
| 2007 FY | 22.14 Million EUR | -2.74% |
| 2006 FY | 22.77 Million EUR | -2.15% |
| 2005 FY | 23.27 Million EUR | -2.19% |
| 2004 FY | 23.79 Million EUR | 21.8% |
| 2003 FY | 19.53 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Almirall, S.A. | -38.47 Million EUR | 338.868% |
| Laboratorio Reig Jofre, S.A. | 9.4 Million EUR | -876.953% |